Stocklytics Platform
Asset logo for symbol ABBV
AbbVie
ABBV60
$185.16arrow_drop_up1.64%$2.99
S&P500
Asset logo for symbol ABBV
ABBV60

$185.16

arrow_drop_up1.64%

AI Deep-Learning Forecast (ABBV)

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

AbbVie (ABBV) Stocklytics Forecast

AbbVie Inc (ABBV) is a global pharmaceutical company that specializes in research, development, and commercialization of advanced therapies in several therapeutic areas. With a diverse portfolio of products, AbbVie is known for its innovative and life-saving medications. In recent years, the company has experienced significant growth and has become a key player in the healthcare industry.
When looking at the stock price forecast for AbbVie Inc, it is important to consider various factors that can influence the future performance of the company. One major factor is the company's pipeline of new drugs and potential blockbuster products. AbbVie has a strong pipeline with several promising candidate drugs in various stages of development. If these drugs receive regulatory approval and successfully hit the market, it could have a positive impact on the company's stock price.
add AbbVie to watchlist

Keep an eye on AbbVie

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for AbbVie (ABBV) stock?
Analysts have set a target price of $182.15 for AbbVie (ABBV), based on forecasts from 27 analysts. The predicted price range extends from a high of $200 to a low of $150. This represents a potential increase of up to 8.01% and a decrease of -18.99% from the current price of $185.16. These forecasts are as of 2023 Apr 28.
help
What are the analyst ratings for AbbVie (ABBV) stock?
The analyst ratings for AbbVie (ABBV) are distributed as follows: 10 analysts recommend buying, 10 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering AbbVie .
help
What is the AI price prediction for AbbVie (ABBV) stock?
At present, there is no AI or machine-learning-based price prediction available for AbbVie (ABBV) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.
email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level